Dominique Missiakas to Staphylococcal Vaccines
This is a "connection" page, showing publications Dominique Missiakas has written about Staphylococcal Vaccines.
Connection Strength
2.203
-
Sortases, Surface Proteins, and Their Roles in Staphylococcus aureus Disease and Vaccine Development. Microbiol Spectr. 2019 01; 7(1).
Score: 0.678
-
Staphylococcus aureus vaccines: Deviating from the carol. J Exp Med. 2016 08 22; 213(9):1645-53.
Score: 0.575
-
Vaccine protection of leukopenic mice against Staphylococcus aureus bloodstream infection. Infect Immun. 2014 Nov; 82(11):4889-98.
Score: 0.502
-
Mouse models for infectious diseases caused by Staphylococcus aureus. J Immunol Methods. 2014 Aug; 410:88-99.
Score: 0.122
-
Exploring Staphylococcus aureus pathways to disease for vaccine development. Semin Immunopathol. 2012 Mar; 34(2):317-33.
Score: 0.104
-
Identifying protective antigens of Staphylococcus aureus, a pathogen that suppresses host immune responses. FASEB J. 2011 Oct; 25(10):3605-12.
Score: 0.101
-
Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice. J Exp Med. 2010 Aug 30; 207(9):1863-70.
Score: 0.095
-
Coagulases as determinants of protective immune responses against Staphylococcus aureus. Infect Immun. 2012 Oct; 80(10):3389-98.
Score: 0.027